ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 111 filers reported holding ACCELERATE DIAGNOSTICS INC in Q4 2016. The put-call ratio across all filers is 3.92 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,000 | -50.0% | 160 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | 0.0% | 160 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | +100.0% | 160 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | -66.7% | 160 | 0.0% | 0.00% | – |
| Q4 2019 | $3,000 | 0.0% | 160 | 0.0% | 0.00% | – |
| Q3 2019 | $3,000 | -25.0% | 160 | 0.0% | 0.00% | – |
| Q2 2019 | $4,000 | +33.3% | 160 | 0.0% | 0.00% | – |
| Q1 2019 | $3,000 | -100.0% | 160 | -99.9% | 0.00% | -100.0% |
| Q4 2018 | $8,709,000 | +217625.0% | 135,735 | +84734.4% | 0.96% | – |
| Q3 2018 | $4,000 | 0.0% | 160 | 0.0% | 0.00% | – |
| Q2 2018 | $4,000 | 0.0% | 160 | 0.0% | 0.00% | – |
| Q1 2018 | $4,000 | 0.0% | 160 | 0.0% | 0.00% | – |
| Q4 2017 | $4,000 | -50.0% | 160 | -50.0% | 0.00% | – |
| Q3 2017 | $8,000 | 0.0% | 320 | 0.0% | 0.00% | -100.0% |
| Q2 2017 | $8,000 | 0.0% | 320 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $8,000 | +33.3% | 320 | 0.0% | 0.00% | – |
| Q4 2016 | $6,000 | – | 320 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 2,065,560 | $39,638,000 | 23.01% |
| Selkirk Management LLC | 165,700 | $3,180,000 | 1.90% |
| Opaleye Management Inc. | 100,000 | $1,919,000 | 0.97% |
| LUCUS ADVISORS LLC | 80,000 | $1,535,000 | 0.68% |
| Miura Global Management | 435,000 | $8,348,000 | 0.63% |
| OBERMEYER WOOD INVESTMENT COUNSEL, LLLP | 276,549 | $5,307,000 | 0.48% |
| Iguana Healthcare Management, LLC | 50,000 | $960,000 | 0.46% |
| BSW Wealth Partners | 22,714 | $436,000 | 0.35% |
| Harvest Capital Strategies LLC | 90,000 | $1,727,000 | 0.19% |
| FAIRFIELD, BUSH & CO. | 35,100 | $674,000 | 0.19% |